Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors.

Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, Nguyen M, Haditsch U, Raha D, Griffin C, Holsinger LJ, Arastu-Kapur S, Kaba S, Lee A, Ryder MI, Potempa B, Mydel P, Hellvard A, Adamowicz K, Hasturk H, Walker GD, Reynolds EC, Faull RLM, Curtis MA, Dragunow M, Potempa J.

Sci Adv. 2019 Jan 23;5(1):eaau3333. doi: 10.1126/sciadv.aau3333. eCollection 2019 Jan.

2.

Impact of Porphyromonas gingivalis Peptidylarginine Deiminase on Bacterial Biofilm Formation, Epithelial Cell Invasion, and Epithelial Cell Transcriptional Landscape.

Aliko A, Kamińska M, Bergum B, Gawron K, Benedyk M, Lamont RJ, Malicki S, Delaleu N, Potempa J, Mydel P.

Sci Rep. 2018 Sep 20;8(1):14144. doi: 10.1038/s41598-018-32603-y.

3.

Correction: Pyocycanin, a Contributory Factor in Haem Acquisition and Virulence Enhancement of Porphyromonas gingivalis in the Lung.

Benedyk M, Byrne DP, Glowczyk I, Potempa J, Olczak M, Olczak T, Smalley JW.

PLoS One. 2016 Jan 25;11(1):e0148008. doi: 10.1371/journal.pone.0148008. eCollection 2016. No abstract available.

4.

Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis.

Benedyk M, Mydel PM, Delaleu N, Płaza K, Gawron K, Milewska A, Maresz K, Koziel J, Pyrc K, Potempa J.

J Innate Immun. 2016;8(2):185-98. doi: 10.1159/000441724. Epub 2015 Nov 28.

5.

Pyocyanina contributory factor in haem acquisition and virulence enhancement of Porphyromonas gingivalis in the lung [corrected].

Benedyk M, Byrne DP, Glowczyk I, Potempa J, Olczak M, Olczak T, Smalley JW.

PLoS One. 2015 Feb 23;10(2):e0118319. doi: 10.1371/journal.pone.0118319. eCollection 2015. Erratum in: PLoS One. 2016;11(1):e0148008.

6.

Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD).

Maresz KJ, Hellvard A, Sroka A, Adamowicz K, Bielecka E, Koziel J, Gawron K, Mizgalska D, Marcinska KA, Benedyk M, Pyrc K, Quirke AM, Jonsson R, Alzabin S, Venables PJ, Nguyen KA, Mydel P, Potempa J.

PLoS Pathog. 2013 Sep;9(9):e1003627. doi: 10.1371/journal.ppat.1003627. Epub 2013 Sep 12.

7.

Expression of S100A8/A9 in HaCaT keratinocytes alters the rate of cell proliferation and differentiation.

Voss A, Bode G, Sopalla C, Benedyk M, Varga G, Böhm M, Nacken W, Kerkhoff C.

FEBS Lett. 2011 Jan 21;585(2):440-6. doi: 10.1016/j.febslet.2010.12.037. Epub 2010 Dec 28.

8.

Strategies for innovation and interdisciplinary translational research: research and career benefits and barriers.

Benedyk M, Berglund L, Facciotti M, Mobley W, Zucker D.

J Investig Med. 2009 Feb;57(2):477-81. doi: 10.2310/JIM.0b013e31819824be.

PMID:
19174698
9.

Expression and localization of Werner syndrome protein is modulated by SIRT1 and PML.

Vaitiekunaite R, Butkiewicz D, Krześniak M, Przybyłek M, Gryc A, Snietura M, Benedyk M, Harris CC, Rusin M.

Mech Ageing Dev. 2007 Nov-Dec;128(11-12):650-61. Epub 2007 Oct 2.

PMID:
17996922
10.

HaCaT keratinocytes overexpressing the S100 proteins S100A8 and S100A9 show increased NADPH oxidase and NF-kappaB activities.

Benedyk M, Sopalla C, Nacken W, Bode G, Melkonyan H, Banfi B, Kerkhoff C.

J Invest Dermatol. 2007 Aug;127(8):2001-11. Epub 2007 Apr 12.

11.

Identification of poly(ADP-ribose)polymerase-1 and Ku70/Ku80 as transcriptional regulators of S100A9 gene expression.

Grote J, König S, Ackermann D, Sopalla C, Benedyk M, Los M, Kerkhoff C.

BMC Mol Biol. 2006 Dec 22;7:48.

12.

The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2.

Kerkhoff C, Nacken W, Benedyk M, Dagher MC, Sopalla C, Doussiere J.

FASEB J. 2005 Mar;19(3):467-9. Epub 2005 Jan 10.

PMID:
15642721

Supplemental Content

Loading ...
Support Center